Financhill
Back

Builders FirstSource Vs. Avidity Biosciences Industry Stock Comparison

Sell
50

BLDR
Builders FirstSource

Last Price:
$127.13
Seasonality Move:
2.31%
Sell
23

RNA
Avidity Biosciences

Last Price:
$29.15
Seasonality Move:
-6.84%
Sell
50
Builders FirstSource (BLDR) is a Sell

Is Builders FirstSource a Buy, Sell or Hold?

  • The current Builders FirstSource [BLDR] share price is $127.22. The Score for BLDR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • BLDR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Avidity Biosciences (RNA) is a Sell

Is Avidity Biosciences a Buy, Sell or Hold?

  • The current Avidity Biosciences [RNA] share price is $29.17. The Score for RNA is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • RNA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BLDR Stock Price Chart

What is Builders FirstSource's stock price today?

  • The Builders FirstSource share price today is $127.22
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BLDR is experiencing slight buying pressure.

RNA Stock Price Chart

What is Avidity Biosciences's stock price today?

  • The Avidity Biosciences share price today is $29.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNA is experiencing slight selling pressure.

BLDR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.94 Buy
Relative Strength Index (14 RSI): 65.12 Buy
Chaikin Money Flow: 228078 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (108.84 - 120.62) Buy
Bollinger Bands (100): (110.56 - 136.22) Buy

RNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.63 Sell
Relative Strength Index (14 RSI): 43.92 Sell
Chaikin Money Flow: -57703 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.9 - 33.42) Sell
Bollinger Bands (100): (27.9 - 32.88) Sell

BLDR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 120.81 Buy
20-day SMA: 116.15 Buy
50-day SMA: 114.79 Buy
200-day SMA: 148.93 Sell
8-day EMA: 121.9 Buy
20-day EMA: 117.73 Buy
50-day EMA: 117.68 Buy
200-day EMA: 137.66 Sell

RNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.25 Sell
20-day SMA: 30.73 Sell
50-day SMA: 30.71 Sell
200-day SMA: 34.88 Sell
8-day EMA: 29.27 Sell
20-day EMA: 30.02 Sell
50-day EMA: 30.41 Sell
200-day EMA: 31.95 Sell

Builders FirstSource Earnings Growth & BLDR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.46 per share, an increase next quarter of $0.27 per share, a decrease this year of $3.10 per share, and an increase next year of $1.48 per share.

Avidity Biosciences Earnings Growth & RNA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.15 per share, a decrease this year of $1.08 per share, and a decrease next year of $0.46 per share.

Builders FirstSource Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Avidity Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):